Cargando…

The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease

BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Chenyu, Dai, Zhiwei, Chai, Lingxiong, Wu, Lingping, Li, Jianhui, Guo, Weiying, Zhang, Jie, Zhang, Qun, Xue, Congping, Lin, Haixue, Luo, Qun, Cai, Kedan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649351/
https://www.ncbi.nlm.nih.gov/pubmed/34689373
http://dx.doi.org/10.1002/jcla.24062
_version_ 1784610978744238080
author Zhong, Chenyu
Dai, Zhiwei
Chai, Lingxiong
Wu, Lingping
Li, Jianhui
Guo, Weiying
Zhang, Jie
Zhang, Qun
Xue, Congping
Lin, Haixue
Luo, Qun
Cai, Kedan
author_facet Zhong, Chenyu
Dai, Zhiwei
Chai, Lingxiong
Wu, Lingping
Li, Jianhui
Guo, Weiying
Zhang, Jie
Zhang, Qun
Xue, Congping
Lin, Haixue
Luo, Qun
Cai, Kedan
author_sort Zhong, Chenyu
collection PubMed
description BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in individuals with DKD and reveal the correlations between SCFAs and renal function. METHODS: A total of 30 participants with DKD, 30 participants with type 2 diabetes mellitus (DM), and 30 normal controls (NC) in HwaMei Hospital were recruited from 1/1/2018 to 12/31/2019. Participants with DKD were divided into low estimated glomerular filtration rate (eGFR)(eGFR<60ml/min, n=14) and high eGFR (eGFR≥60ml/min, n=16) subgroups. Stool and serum were measured for SCFAs with gas chromatograph‐mass spectrometry. RESULTS: The DKD group showed markedly lower levels of fecal acetate, propionate, and butyrate versus NC (p<0.001, p<0.001, p=0.018, respectively) [1027.32(784.21–1357.90)]vs[2064.59(1561.82–2637.44)]μg/g,[929.53(493.65–1344.26)]vs[1684.57(1110.54–2324.69)]μg/g,[851.39(409.57–1611.65)] vs[1440.74(1004.15–2594.73)]μg/g, respectively, and the lowest fecal total SCFAs concentration among the groups. DKD group also had a lower serum caproate concentration than that with diabetes (p=0.020)[0.57(0.47–0.61)]vs[0.65(0.53–0.79)]μmol/L. In the univariate regression analysis, fecal and serum acetate correlated with eGFR (OR=1.013, p=0.072; OR=1.017, p=0.032). The correlation between serum total SCFAs and eGFR showed statistical significance (OR=1.019, p=0.024) unadjusted and a borderline significance (OR=1.024, p=0.063) when adjusted for Hb and LDL. The decrease in serum acetate and total SCFAs were found of borderline significant difference in both subgroups (p=0.055, p=0.050). CONCLUSION: This study provides evidence that in individuals with DKD, serum and fecal SCFAs levels (fecal level in particular) were lowered, and there was a negative correlation between SCFAs and renal function.
format Online
Article
Text
id pubmed-8649351
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86493512021-12-28 The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease Zhong, Chenyu Dai, Zhiwei Chai, Lingxiong Wu, Lingping Li, Jianhui Guo, Weiying Zhang, Jie Zhang, Qun Xue, Congping Lin, Haixue Luo, Qun Cai, Kedan J Clin Lab Anal Research Articles BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in individuals with DKD and reveal the correlations between SCFAs and renal function. METHODS: A total of 30 participants with DKD, 30 participants with type 2 diabetes mellitus (DM), and 30 normal controls (NC) in HwaMei Hospital were recruited from 1/1/2018 to 12/31/2019. Participants with DKD were divided into low estimated glomerular filtration rate (eGFR)(eGFR<60ml/min, n=14) and high eGFR (eGFR≥60ml/min, n=16) subgroups. Stool and serum were measured for SCFAs with gas chromatograph‐mass spectrometry. RESULTS: The DKD group showed markedly lower levels of fecal acetate, propionate, and butyrate versus NC (p<0.001, p<0.001, p=0.018, respectively) [1027.32(784.21–1357.90)]vs[2064.59(1561.82–2637.44)]μg/g,[929.53(493.65–1344.26)]vs[1684.57(1110.54–2324.69)]μg/g,[851.39(409.57–1611.65)] vs[1440.74(1004.15–2594.73)]μg/g, respectively, and the lowest fecal total SCFAs concentration among the groups. DKD group also had a lower serum caproate concentration than that with diabetes (p=0.020)[0.57(0.47–0.61)]vs[0.65(0.53–0.79)]μmol/L. In the univariate regression analysis, fecal and serum acetate correlated with eGFR (OR=1.013, p=0.072; OR=1.017, p=0.032). The correlation between serum total SCFAs and eGFR showed statistical significance (OR=1.019, p=0.024) unadjusted and a borderline significance (OR=1.024, p=0.063) when adjusted for Hb and LDL. The decrease in serum acetate and total SCFAs were found of borderline significant difference in both subgroups (p=0.055, p=0.050). CONCLUSION: This study provides evidence that in individuals with DKD, serum and fecal SCFAs levels (fecal level in particular) were lowered, and there was a negative correlation between SCFAs and renal function. John Wiley and Sons Inc. 2021-10-24 /pmc/articles/PMC8649351/ /pubmed/34689373 http://dx.doi.org/10.1002/jcla.24062 Text en © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zhong, Chenyu
Dai, Zhiwei
Chai, Lingxiong
Wu, Lingping
Li, Jianhui
Guo, Weiying
Zhang, Jie
Zhang, Qun
Xue, Congping
Lin, Haixue
Luo, Qun
Cai, Kedan
The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title_full The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title_fullStr The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title_full_unstemmed The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title_short The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
title_sort change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649351/
https://www.ncbi.nlm.nih.gov/pubmed/34689373
http://dx.doi.org/10.1002/jcla.24062
work_keys_str_mv AT zhongchenyu thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT daizhiwei thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT chailingxiong thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT wulingping thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT lijianhui thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT guoweiying thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT zhangjie thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT zhangqun thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT xuecongping thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT linhaixue thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT luoqun thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT caikedan thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT zhongchenyu changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT daizhiwei changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT chailingxiong changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT wulingping changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT lijianhui changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT guoweiying changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT zhangjie changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT zhangqun changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT xuecongping changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT linhaixue changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT luoqun changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease
AT caikedan changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease